Your browser doesn't support javascript.
loading
Nonclinical Safety Testing of RNA Vaccines.
Hager, Gundel.
Afiliação
  • Hager G; Aurigon GmbH, Machtlfinger Str. 13, 81379, Munich, Germany. gundel.hager@aurigon.de.
Methods Mol Biol ; 1499: 253-272, 2017.
Article em En | MEDLINE | ID: mdl-27987155
ABSTRACT
In this chapter, we first consider the overall goal of nonclinical safety testing during drug development and have a brief overview of its regulatory background. We then discuss some basic requirements of safety/toxicity testing before concentrating on the safety testing of RNA vaccines and developing a sample RNA vaccine safety testing program.
Assuntos
Palavras-chave
Buscar no Google
Base de dados: MEDLINE Assunto principal: RNA / Vacinas Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: RNA / Vacinas Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article